Total Payments
$2,216
2024 Payments
$96.91
Companies
24
Transactions
74
Medicare Patients
1,026
Medicare Billing
$105,836
Payment Breakdown by Category
Food & Beverage$2,216 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,216 | 74 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $640.07 | 18 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $331.60 | 4 | $0 (2020) |
| Biohaven Pharmaceutical Holding Company Ltd. | $212.26 | 2 | $0 (2022) |
| Shire North American Group Inc | $130.29 | 4 | $0 (2017) |
| Biohaven Pharmaceuticals, Inc. | $119.39 | 1 | $0 (2021) |
| Lilly USA, LLC | $111.45 | 6 | $0 (2021) |
| IDORSIA PHARMACEUTICALS US INC | $97.61 | 1 | $0 (2023) |
| Aytu BioScience, Inc | $95.70 | 8 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $93.26 | 5 | $0 (2021) |
| Purdue Pharma L.P. | $61.28 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $96.91 | 2 | Amgen Inc. ($80.82) |
| 2023 | $237.48 | 5 | Amgen Inc. ($139.87) |
| 2022 | $244.73 | 4 | Biohaven Pharmaceutical Holding Company Ltd. ($212.26) |
| 2021 | $274.05 | 12 | Biohaven Pharmaceuticals, Inc. ($119.39) |
| 2020 | $538.91 | 17 | Amgen Inc. ($212.00) |
| 2019 | $345.89 | 10 | Amgen Inc. ($150.41) |
| 2018 | $80.22 | 6 | Aytu BioScience, Inc ($50.18) |
| 2017 | $397.71 | 18 | Shire North American Group Inc ($130.29) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $80.82 | General |
| Category: Cardiology | ||||||
| 04/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/30/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: Cardiology | ||||||
| 11/30/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: Cardiology | ||||||
| 07/27/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $97.61 | General |
| Category: INSOMNIA | ||||||
| 07/26/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $118.08 | General |
| Category: Cardiology | ||||||
| 06/27/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $6.77 | General |
| Category: Cardiology | ||||||
| 10/27/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 05/18/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $93.58 | General |
| Category: PRIMARY CARE | ||||||
| 04/27/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 02/01/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $118.68 | General |
| Category: PRIMARY CARE | ||||||
| 11/10/2021 | Clarus Therapeutics Inc. | JATENZO (Drug), JATENZO, JATENZO | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 11/10/2021 | Clarus Therapeutics Inc. | JATENZO (Drug), JATENZO, JATENZO | Food and Beverage | In-kind items and services | $2.29 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 10/04/2021 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Inflammation | ||||||
| 08/04/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Neuroscience | ||||||
| 06/23/2021 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Inflammation | ||||||
| 06/22/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $119.39 | General |
| Category: PRIMARY CARE | ||||||
| 06/01/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Neuroscience | ||||||
| 04/28/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2021 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Inflammation | ||||||
| 02/24/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Neuroscience | ||||||
| 01/13/2021 | Clarus Therapeutics Inc. | JATENZO (Drug), JATENZO, JATENZO | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 12/16/2020 | DERMIRA, INC. | QBREXZA (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 154 | 210 | $29,145 | $10,138 |
| 2022 | 5 | 279 | 500 | $72,480 | $34,706 |
| 2021 | 5 | 323 | 506 | $73,500 | $39,306 |
| 2020 | 6 | 270 | 385 | $52,675 | $21,686 |
Total Patients
1,026
Total Services
1,601
Medicare Billing
$105,836
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 87 | $14,355 | $4,385 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 72 | $9,000 | $2,791 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $5,500 | $2,719 | 49.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 29 | 29 | $290.00 | $243.60 | 84.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 184 | $30,360 | $15,009 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 176 | $22,000 | $9,795 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 39 | 39 | $9,750 | $4,932 | 50.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 39 | $9,750 | $4,787 | 49.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 51 | 62 | $620.00 | $183.60 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 99 | 213 | $35,145 | $19,762 | 56.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 148 | $18,500 | $9,065 | 49.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 50 | 50 | $12,500 | $6,448 | 51.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 28 | $6,685 | $3,829 | 57.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 61 | 67 | $670.00 | $201.00 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 84 | 135 | $22,275 | $9,621 | 43.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 79 | 135 | $16,875 | $6,061 | 35.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 27 | 27 | $6,750 | $3,049 | 45.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 11 | 11 | $3,080 | $1,544 | 50.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 13 | 15 | $3,075 | $1,226 | 39.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 56 | 62 | $620.00 | $185.22 | 29.9% |
About Dr. Daniel Forrer, DO
Dr. Daniel Forrer, DO is a Family Medicine healthcare provider based in Bartonville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932161148.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Forrer, DO has received a total of $2,216 in payments from pharmaceutical and medical device companies, with $96.91 received in 2024. These payments were reported across 74 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,216).
As a Medicare-enrolled provider, Forrer has provided services to 1,026 Medicare beneficiaries, totaling 1,601 services with total Medicare billing of $105,836. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bartonville, TX
- Active Since 04/04/2006
- Last Updated 07/12/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1932161148
Products in Payments
- Repatha (Biological) $392.69
- NURTEC ODT (Drug) $331.65
- Aimovig (Biological) $201.92
- AJOVY (Drug) $125.80
- MYDAYIS (Drug) $120.08
- AJOVY (Biological) $113.97
- QUVIVIQ (Drug) $97.61
- Natesto (Drug) $95.70
- EMGALITY (Drug) $93.76
- TRINTELLIX (Drug) $93.26
- AIRDUO (Drug) $91.83
- Otezla (Drug) $45.46
- AIMOVIG (Biological) $35.65
- JATENZO (Drug) $34.14
- NOCDURNA (Drug) $32.47
- Trintellix (Drug) $32.02
- ALINIA (Drug) $24.52
- QBREXZA (Drug) $20.04
- TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug) $18.66
- REYVOW (Drug) $17.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.